Meriden Pharmacy Reaches Settlement With Federal Government

MERIDEN, CT — The owner of a Meriden pharmacy has reached an agreement with the federal government to resolve allegations that the business violated the Controlled Substances Act, according to a statement from prosecutors.

The case stems from an audit of Graeber's Pharmacy in 2018 when Drug Enforcement Administration officials found a shortage of more than 2,000 tablets of various controlled substances. Prosecutors claim the pharmacy failed to keep complete and accurate records regarding the receipt and dispensing of controlled substances, and failed to maintain effective controls to guard against the diversion of controlled substances, according to the statement.

The pharmacy was also accused of failing to timely report a theft or loss of controlled substances to the DEA within one business day of discovery, among other allegations.

Per the civil settlement with the government, the pharmacy will pay penalties of $16,800 plus interest. The pharmacy will also be required to hire an independent third-party pharmacy consultant.